Pyrimidinone and its derivatives inhibiting factor XIa
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 21, 2020
Grant Date -
Oct 26, 2017
app pub date -
Jul 7, 2017
filing date -
Dec 21, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides compounds of the general formula (I), their salts and N-oxides, and solvates and prodrugs thereof (wherein the characters are as defined in the description). The compounds of the general formula (I) are inhibitors of Factor XIa, so that they are useful in the prevention of and/or therapy for thromboembolic diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully